A detailed history of Jpmorgan Chase & CO transactions in Medtronic PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 31,626,896 shares of MDT stock, worth $2.57 Billion. This represents 0.25% of its overall portfolio holdings.

Number of Shares
31,626,896
Previous 25,385,137 24.59%
Holding current value
$2.57 Billion
Previous $2.09 Billion 31.8%
% of portfolio
0.25%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$82.84 - $88.09 $517 Million - $550 Million
6,241,759 Added 24.59%
31,626,896 $2.76 Billion
Q4 2023

Feb 12, 2024

BUY
$69.43 - $83.43 $383 Million - $461 Million
5,522,685 Added 27.8%
25,385,137 $2.09 Billion
Q3 2023

Nov 14, 2023

BUY
$78.22 - $90.4 $16.7 Million - $19.3 Million
213,271 Added 1.09%
19,862,452 $1.56 Billion
Q2 2023

Aug 11, 2023

SELL
$79.47 - $91.38 $55.7 Million - $64 Million
-700,802 Reduced 3.44%
19,649,181 $1.73 Billion
Q1 2023

May 18, 2023

BUY
$76.72 - $87.58 $48 Million - $54.8 Million
626,051 Added 3.17%
20,349,983 $1.64 Billion
Q1 2023

May 11, 2023

SELL
$76.72 - $87.58 $22.9 Million - $26.1 Million
-298,314 Reduced 1.49%
19,723,932 $1.59 Billion
Q4 2022

Feb 13, 2023

SELL
$76.18 - $87.74 $84.5 Million - $97.3 Million
-1,109,473 Reduced 5.25%
20,022,246 $1.56 Billion
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $299 Million - $353 Million
3,708,132 Added 21.28%
21,131,719 $1.71 Billion
Q2 2022

Aug 11, 2022

SELL
$87.4 - $113.09 $126 Million - $163 Million
-1,437,047 Reduced 7.62%
17,423,587 $1.56 Billion
Q1 2022

May 11, 2022

SELL
$100.58 - $112.38 $43.6 Million - $48.8 Million
-433,883 Reduced 2.25%
18,860,634 $2.09 Billion
Q4 2021

Feb 10, 2022

SELL
$99.53 - $127.75 $458 Million - $588 Million
-4,600,966 Reduced 19.25%
19,294,517 $2 Billion
Q3 2021

Nov 12, 2021

BUY
$122.75 - $135.17 $2.93 Billion - $3.23 Billion
23,895,483 New
23,895,483 $3 Billion

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.